ProCE Banner Activity

Evaluating and Managing High-Risk Disease in HR+/HER2- EBC With and Without gBRCA

Slideset Download
Get up to date on perioperative treatment options for patients with high-risk HR+/HER2- early breast cancer.

Released: December 07, 2022

Expiration: December 06, 2023

No longer available for credit.

Share

Faculty

Tiffany A. Traina

Tiffany A. Traina, MD

Assistant Attending
Breast Medicine Service
Memorial Sloan Kettering Cancer Center
Assistant Professor
Department of Medicine
Weill Medical College of Cornell University
New York, New York

Provided by

Provided by Clinical Care Options, LLC.
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca Pharmaceuticals

Lilly

Merck Sharp & Dohme, LLC

Sanofi

Faculty Disclosure

Primary Author

Tiffany A. Traina, MD

Assistant Attending
Breast Medicine Service
Memorial Sloan Kettering Cancer Center
Assistant Professor
Department of Medicine
Weill Medical College of Cornell University
New York, New York